These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 17032147)
1. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis. Kominsky SL; Doucet M; Brady K; Weber KL J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone. Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339 [TBL] [Abstract][Full Text] [Related]
3. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice. Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601 [TBL] [Abstract][Full Text] [Related]
4. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181 [TBL] [Abstract][Full Text] [Related]
5. Macrophage inflammatory protein-1 delta: a novel osteoclast stimulating factor secreted by renal cell carcinoma bone metastasis. Kominsky SL; Abdelmagid SM; Doucet M; Brady K; Weber KL Cancer Res; 2008 Mar; 68(5):1261-6. PubMed ID: 18316587 [TBL] [Abstract][Full Text] [Related]
6. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F; Lee J; Lu S; Pettaway CA; Dong Z Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637 [TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest. Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines. Shimabukuro T; Ohmoto Y; Naito K J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863 [TBL] [Abstract][Full Text] [Related]
9. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532 [TBL] [Abstract][Full Text] [Related]
10. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination. Perry K; Wong L; Liu V; Park I; Zhang Q; Rejen V; Huang X; Smith ND; Jovanovic B; Lonning S; Teicher BA; Lee C Urology; 2008 Jul; 72(1):225-9. PubMed ID: 18295867 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Guo Y; Kyprianou N Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Masi L; Malentacchi C; Campanacci D; Franchi A Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923 [TBL] [Abstract][Full Text] [Related]
13. MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-beta1. Kominsky SL; Doucet M; Thorpe M; Weber KL Clin Exp Metastasis; 2008; 25(8):865-70. PubMed ID: 18709334 [TBL] [Abstract][Full Text] [Related]
14. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo. Moore LD; Isayeva T; Siegal GP; Ponnazhagan S Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line. Okamoto M; Oyasu R Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901 [TBL] [Abstract][Full Text] [Related]
17. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491 [TBL] [Abstract][Full Text] [Related]
18. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model. Weber KL; Pathak S; Multani AS; Price JE J Urol; 2002 Aug; 168(2):774-9. PubMed ID: 12131367 [TBL] [Abstract][Full Text] [Related]
19. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. Bandyopadhyay A; Zhu Y; Cibull ML; Bao L; Chen C; Sun L Cancer Res; 1999 Oct; 59(19):5041-6. PubMed ID: 10519421 [TBL] [Abstract][Full Text] [Related]
20. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines. Kloth JN; Fleuren GJ; Oosting J; de Menezes RX; Eilers PH; Kenter GG; Gorter A Carcinogenesis; 2005 Sep; 26(9):1493-502. PubMed ID: 15878915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]